GALE Related Corporate News

Dec 18, 2012 09:01 AM Galena Biopharma (GALE) Prices 15.2M Offering at $1.60/Unit

Dec 7, 2012 07:12 AM Galena (GALE) Presents New Data on SN-33, NeuVax Phase 1/2

Dec 6, 2012 07:08 AM Galena Biopharma (GALE), Leica Biosystems Enter NeuVax Partnership

Dec 4, 2012 07:08 AM Galena Biopharma (GALE) Enters NeuVax Commercialization Agreement w/ Teva (TEVA)

Oct 26, 2012 07:09 AM Galena Biopharma (GALE) Presents Data from NeuVax Phase 1/2 in Breast Cancer

Aug 13, 2012 07:10 AM Galena Biopharma (GALE) Gets Japanese Patent for FBP Peptide Variants

Jul 18, 2012 07:13 AM Galena Biopharma (GALE) Receives NeuVax Patent

Jun 5, 2012 07:08 AM Galena Biopharma (GALE) NeuVax Continues w/ Strong Safety Profile

Jun 4, 2012 07:07 AM Galena Biopharma (GALE) Updates from NeuVax Phase 1/2 Following Booster Inoculations; Will Present at ASCO

May 23, 2012 11:45 AM Galena Biopharma (GALE) Withdraws S-3 Registration; Shares Moving Higher

May 1, 2012 07:06 AM Galena Biopharma (GALE) Gets U.S. Patent Allowance for FBP Peptide Variants

Apr 16, 2012 07:05 AM Galena Biopharma (GALE) Closes 9.75M Common Offering

Apr 5, 2012 08:41 AM Galena (GALE) Prices 8.5M Offering at $1.50/Share

Mar 20, 2012 07:15 AM Galena Biopharma (GALE) Receives Notice of Allowance for US Patent Related to NeuVax

Feb 14, 2012 07:06 AM Galena Biopharma (GALE) Initiates E39 Phase 1/2 in Two Gynecological Cancers

Jan 20, 2012 07:06 AM Galena Biopharma (GALE) Initiates NeuVax Phase 3

Dec 9, 2011 07:06 AM Galena Biopharma (GALE) Updates on NeuVax w/ Herceptin Phase 2 Design

Dec 7, 2011 09:01 AM Shares of Galena Biopharma (GALE) Trade up 22% on 5 Year NeuVax Efficacy Data

Dec 7, 2011 07:06 AM Galena (GALE) Reports Statistically Significant Data for NeuVax from Phase 2

Nov 28, 2011 08:24 AM Shares of Galena Biopharma (GALE) Trade Up on Collaboration With Genentech/Roche & The Henry M. Jackson Foundation

Nov 18, 2011 07:07 AM Galena Biopharma (GALE) Will Make Two E75-Related Presentations at Upcoming CTRC-AACR Symposium